Live Long Enough
to live
Forever
RAY KURZWEIL
CTO-GOOGLE
Coming Soon
Why?
ā
Humanity is on the brink of an unprecedented revolution due to scientific advancements in various fields. These breakthroughs are transforming the medical paradigm, particularly in enhancing human longevity. Artificial intelligence (AI) plays a crucial role by efficiently processing data and devising solutions, impacting all aspects of medicine from research to individualized treatment. The complete mapping of human DNA and understanding of epigenetics, coupled with nanotechnology, is set to introduce nanorobots into our bodies. These nanorobots will monitor and address health issues internally. Furthermore, progress in creating artificial organs using technologies like 3D printers and stem cells is notable. The convergence of these technologies is expected to dramatically increase human life expectancy, creating a cycle where extended lifespans lead to more scientific advancements, further prolonging healthy human life.
Personalities of longevity industry
They are the people behind the longevity industry, from scientists to communicators, who are currently contributing to improving human health with their work, increasing life expectancy.
Adam Hornsby
Cognitive Science PhD
Adam, a Senior Data Scientist at dunnhumby and part-time PhD student at UCL, focuses on understanding customer behavior by integrating data science with cognitive modeling.
Adelaida Palla
Scientist at Biogen
Adelaida Palla, Scientist I at Biogen, specialized in pluripotency factor NANOG research, applicable to adult tissues and cancer, with expertise in molecular and cellular techniques.
Abraham Heifets
CEO of Atomwise, Inc.
Abraham Heifets, with a PhD from the University of Toronto, explores molecular prediction methods and has a background in AI for organic synthesis and high-performance XML processing.
Aaron Jeffries
Mental Health First Aider & Advocate
Aaron Jeffries, a Senior Research Fellow at the University of Exeter, is known for his extensive work on ring chromosome 22 and studies in allele-specific cell expression using stem cells.
Aaron Ciechanover
2004 Nobel Prize in Chemistry
Nobel Laureate Aaron Ciechanover, chair of CropX's Scientific Board, pioneered research in protein degradation, contributing to cancer treatment developments, and is a distinguished member of global scientific communities.
A.N. Chandramouli
CEO - ANCM
In a 40-year industrial career, A.N. Chandramouli has excelled in leadership roles, fostering technology collaboration, innovation, and a strong customer focus in diverse sectors.